AI Analysis AI Analysis of BMY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BMY to Watchlist?
Some Reasons Why To Add BMY:
  • Beat earnings estimates in all of the last 4 quarters
  • Excellent financial health (Piotroski 8/9)
  • Strong return on equity of 39.0%
PDF

Stronger technical forecast for Bristol-Myers Squibb stock price after Monday trading
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jul 13, 2026

The Bristol-Myers Squibb stock price gained 3.06% on the last trading day (Monday, 13th Jul 2026), rising from $57.58 to $59.34. During the last trading day the stock fluctuated 3.30% from a day low at $57.54 to a day high of $59.44. The price has been going up and down for this period, and there has been a 3.16% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 821 thousand more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $713.45 million.

Given the current short-term trend, the stock is expected to fall -3.18% during the next 3 months and, with a 90% probability hold a price between $51.82 and $57.45 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BMY Signals & Forecast

Mostly positive signals in the chart today. The Bristol-Myers Squibb stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $57.89 and $56.74. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 9.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Bristol-Myers Squibb stock

Bristol-Myers Squibb finds support from accumulated volume at $57.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.90 (3.30%) between high and low. For the last week, the stock has had daily average volatility of 1.96%.

Our recommended stop-loss: $56.56 (-4.69%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (BMY) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Bristol-Myers Squibb Company to open at $58.77, and during the day (based on 14 day Average True Range), to move between $58.64 and $60.04, which gives a possible trading interval of +/-$1.41 (+/-2.40%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 2.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $59.39 (0.08%) than the support at $57.52 (3.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bristol-Myers Squibb Company stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 3.664 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $58.77 ( 0.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BMY Performance

Trading levels for BMY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 60.67 2.25%
R2 59.95 1.02%
R1 59.50 0.268%
Price 59.34
S1 58.05 -2.18%
S2 57.60 -2.93%
S3 56.87 -4.16%

Accumulated Volume Support & Resistance Levels

Level Price
R3 60.59 2.11%
R2 60.17 1.40%
R1 59.39 0.0843%
Price 59.34
S1 57.52 -3.07%
S2 54.95 -7.40%
S3 54.00 -9.00%

BMY Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 02, 2026 Jul 02, 2026 Aug 03, 2026 $0.630 1.17%
2 Mar 02, 2026 Apr 02, 2026 May 01, 2026 $0.630 1.01%
3 Jan 02, 2026 Jan 02, 2026 Feb 02, 2026 $0.630 1.20%
4 Sep 17, 2025 Oct 03, 2025 Nov 03, 2025 $0.620 1.38%
5 Jun 17, 2025 Jul 03, 2025 Aug 01, 2025 $0.620 1.33%

FAQ

What is the symbol for Bristol-Myers Squibb Stock and on which exchange is it traded?
The symbol for Bristol-Myers Squibb is BMY and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Bristol-Myers Squibb Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Bristol-Myers Squibb Stock?
Bristol-Myers Squibb Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bristol-Myers Squibb Stock.

What's the current price of Bristol-Myers Squibb Stock?
As of the end of day on the Jul 13, 2026, the price of an Bristol-Myers Squibb (BMY) share was $59.34.

What is the 52-week high and low for Bristol-Myers Squibb Stock?
The 52-week high for Bristol-Myers Squibb Stock is $62.89 and the 52-week low is $42.52.

What is the market capitalization of Bristol-Myers Squibb Stock?
As of the Jul 13, 2026, the market capitalization of Bristol-Myers Squibb is 121.176B.

When is the next earnings date for Bristol-Myers Squibb?
The upcoming earnings date for Bristol-Myers Squibb is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT BRISTOL-MYERS SQUIBB COMPANY
Bristol-Myers Squibb
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE